ArticleNPJ digital medicine2026
Construction of virtual whole eye model based on ultra-widefield optical coherence tomography in myopia.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Recognizing the inconvenience of magnetic resonance imaging (MRI) in evaluating the ocular morphology, this study developed a three-dimensional virtual whole eye model (CET-1) using ultra-widefield swept-source optical coherence tomography. The CET-1 were validated with MRI models in 80 eyes from 40 individuals with different extent of myopia. The result showed these two models have high consistency across different axial lengths (22.19 to 32.56 mm) -calculated as the mean point-to-surface distance, measuring 0.0183 ± 0.0025 normalized unit (439.57 ± 59.87 μm). Compared to the normal group, both of the posterior segment Gaussian curvature and anterior segment parameters demonstrated a significant change in myopic groups (P < 0.05). The CET-1 model provides a simple and effective tool that enables the establishment of a digital twin ocular model, facilitating the monitoring and quantitative analysis of myopia development and progression. Thus, supports optimized treatment strategies and contributes to the advancement of personalized medicine.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.